◼ Archived
Business
🔮 Archynetys predicts: fades by tomorrow — graded ✓ correct
FDA reverses course on Regenxbio’s childhood gene therapy after rejection
0sources
0articles
0velocity
22d agofirst detected
Velocity
How fast coverage is spreading — measured hourly from article rate × source diversity. How this works →
Coverage (0)
Related trends
▲ Peaking
Business
Realta Fusion will develop former Oscar Mayer site in Madison, add 600 jobs
U.S. startup Realta Fusion is transforming the former Oscar Mayer plant in Madison into a fusion energy hub.
▲ Peaking
Business
Russian hackers exploiting vulnerable internet routers, NSA warns
▲ Peaking
Business
BYD says demand is ‘booming’ for the new Denza Z EV as global pre-orders top 1,000
BYD reports booming global demand for the Denza Z EV, with pre-orders exceeding 1,000 units.
▲ Peaking
Business
Report: How an email mistake derailed talks between Apple and OpenAI ahead of the lawsuit
▲ Peaking
Business
FCC Moves to End Cap on National Broadcast Ownership
The FCC is moving to repeal the 39% national ownership cap, potentially opening the door for larger TV station mergers.
▲ Peaking
Business